Kythera Biopharmaceuticals to Present at Leerink Swann and Company 2012 Global Healthcare Conference

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (KYTHERA), a privately held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, announced today that Keith Leonard, President and Chief Executive Officer, will present a corporate overview at the Leerink Swann 2012 Global Healthcare Conference in New York City.
MORE ON THIS TOPIC